In brief, flavonoids reduce androgen levels and improve hyperandrogenism mainly by inhibiting the activities of 3β-HSD, 17β-HSD, and aromatase, thereby inhibiting androgen conversion. The gene discussed is CYP19A1; the disease is hyperandrogenism.